Activity from announced rounds
Future Ventures is the investment firm associated with Steve Jurvetson and Maryanna Saenko, identified by Modulate and in its own Moonwalk news.
Modulate develops models that analyze voice conversations beyond transcripts. Moonwalk develops fat-tissue-targeted medicines, while Shennon develops cancer immunotherapies. These relationships identify the firm separately from the unrelated Indian namesake.
Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.